A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS).
Autoimmune Disorder Multiple Sclerosis (MS)
For the latest version of this information please go to www.forpatients.roche.com